Publication for Cdkn1a and Phlda3
Species | Symbol | Function* | Entrez Gene ID* | Other ID | Gene coexpression |
CoexViewer |
---|---|---|---|---|---|---|
mmu | Cdkn1a | cyclin-dependent kinase inhibitor 1A (P21) | 12575 | [link] | ||
mmu | Phlda3 | pleckstrin homology like domain, family A, member 3 | 27280 |
Pubmed ID | Priority | Text |
---|---|---|
29351057 | 0.98 | Cdkn1a (up 18-fold), Mdm2 (up 2.8-fold) and Phlda3 (up 6.5-fold). |
0.98 | Cdkn1a, Aen, Phlda3, Bbc3 and Mdm2. | |
0.97 | Cdkn1a and Phlda3, were upregulated, although to a lesser degree, in SCID mice | |
0.88 | Cdkn1a and Phlda3 were upregulated 7.8-fold and 3.4-fold, respectively, in SCID) and involved fewer genes overall. | |
30605667 | 0.98 | Phlda3, and Cdkn1a, were found among the upregulated transcripts in Bmi1-/- pro-B cells (Figure 4A; Table S1). |
0.98 | Phlda3, and Cdkn1a, in Bmi1-/- pro-B cells from independent animals (Figure 4B). | |
20628553 | 0.98 | p21CIP1 and Phlda3, were upregulated in Hdac3 CKO mice. |
22579044 | 0.98 | Cdkn1a/p21, Phlda3, and Trp53inp1, were all targets of the p53 transcriptional activator, a key transducer of ATM/ATR DNA damage signaling. |
23085085 | 0.98 | p21CIP1 and Phlda3, were also upregulated in Hdac3 CKOOSX mice, and BMSC exposed to the pan-Hdac inhibitor vorinostat during osteoblastic differentiation demonstrated DNA damage and cell cycle arrest. |
31659152 | 0.98 | Cdkn1a and two pro-apoptotic genes Trp53inp1 and PHLDA3 in Ppm1dT/+ confirming that truncated Ppm1d impairs the p53-dependent response of colon ISCs to genotoxic stress (Fig. 3c, Supplementary Fig. S2). |
27482301 | 0.97 | Cdkn1a, Gadd45b, Gadd45g, Phlda3, and Mdm2] of 18 genes, which showed statistically significant increases, were associated with cancer, cell cycle, cell death and survival, and cellular growth and proliferation. |
0.96 | Cdkn1a, Mdmd2, Btg2, Ccng1, Ddit4, Gdf15, Hist1h1c, Hmox1, Hspb1, Phlda3, Plk2, and Pml] identified in this study have been reported to be directly associated with Trp53. | |
0.93 | Cdkn1a, Egfr, Gdf15, Hist1h1c, Jun, Lrp1, Mbd1, Mdm2, Phlda3, Plk2, Pml, Ppp1r3c, and Tubb4b (Tubb2c)] at 4 h, and 19 genes [Aen, Bax, Btg2, Ccnf, Ccng1, Cdkn1a, Ddit4l, Ephx1, Gadd45b, Gdf15, Lrp1, Ly6a, Mdm2, Phlda3, Plk2, Pmm1, Ppp1r3c, St3gal5, and Tubb4b (Tubb2c)] at 48 h showed a statistical significance between the genotoxic and non-genotoxic hepatocarcinogens, as analyzed by the Welch's test. | |
0.54 | Cdkn1a, Cyp1a2, Ddit4, Ddit4l, Egfr, Ephx1, Gadd45b, Gdf15, HistH1, Hmox1, Hspb1, Igfbp1, Jun, Lrp1, Ly6a, Mbd1, Mdm2, Phlda3, Plk2, Pml, Pmm1, Ppp1r3c, Psma3, Rad52, Rcan1, St3gal5, Trp53, and Tubb4b (Tubb2c)] showed statistically significant changes in their gene expression, at least once at 4 h and/or 48 h, as computed by the Dunnett's test using the Gapdh gene to normalize the data. | |
30166543 | 0.97 | Cdkn1a, Sesn2, Ddit4, Pmaip1, Zmat3 and Phlda3), antigen processing and presentation (H2-DMb2, CD74, H2-Aa, H2-Eb1, H2-Q1, H2-T3 and H2-Q6) and T-cell differentiation (Supplementary Data 1). |
30770771 | 0.97 | Cdkn1a, Hmox1, Phlda3, and Trp53inp1) are associated with apoptosis and/or stress response (Hspb1, Ephx1) |
29746213 | 0.96 | Cdkn1a and Phlda3) and mediators of inflammatory response (Il1b) in the Parp1-/- mice responding to radiation. |
31492921 | 0.96 | Cdkn1a (also known as p21) were not affected by Phlda3 inhibition (Fig. 8k,l). |
29396430 | 0.94 | p21, PHLDA3, FUCA1, IER5, PLK2, RPRM, PMAIP1 and PTP4A1, Fig. S1C-K). |
31046668 | 0.92 | Cdkn1a, Phlda3, Ifitm1 and Ifit3 (Additional file 6) suggests that the relative responses of the Trp53 regulated genes in the two strains are similar at low and high doses. |
0.53 | Cdkn1a, Aen, Phlda3, Ccng1, Ifitm1, Ifit3) showing significant difference in expression in Il10-/- mice compared to WT after radiation exposure are presented here. | |
25162453 | 0.84 | Cdkn1a and Phlda3 also showed the same time-dependent pattern of relative expression evident from the microarray data, with expression rising over the first few days after injection to 25-fold and 4.6-fold by day 3, then dropping to near control levels by day 30 despite continued accumulation of total dose. |
28930658 | 0.83 | Phlda3), vitamin-B1/Thiamin homeostasis (Slc19a2), pro-apoptotic/ tumor suppressor (Sesn2, Phlda3, Slc19a2), cell-cycle arrest (Cdkn1a), and negative regulation of p53 activity (Mdm2) (data not shown). |
0.68 | Phlda3, and Sesn2) and the 2 p53-dependent ERGs induced by both IR and Lipid A (Mdm2 and Cdkn1a) (Figure 7B; see also Figure 6D). | |
22610609 | 0.78 | Cdkn1a), growth differentiation factor 15 (Gdf15), carboxylesterase 5 (Ces5), pleckstrin homology-like domain, family A, member 3 (Phlda3), multimerin 2 (Mmrn2), cyclin G1 (Ccng1), serum amyloid A 3 (Saa3), and sestrin 2 (Sesn2) were the most upregulated genes in all the dose groups. |
25987256 | 0.77 | Cdkn1a, Ptp4a3, Zmat3, Bax, Ccng1 and Phlda3) in c-Kit-enriched hematopoietic progenitor cells. |
The preparation time of this page was 0.0 [sec].